The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms

NCT07073053 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Glucagon-Like Peptide-1 Receptor Agonists
Type 2 Diabetes
Coronary Arterial Disease (CAD)

Interventions

DRUG: Semaglutide 1.0 mg
DRUG: Semaglutide 0.5 mg

Sponsor

Taipei Veterans General Hospital, Taiwan